digoxigenin has been researched along with Carcinoma in Situ in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiu, SC; Harn, HJ; Ho, LI; Lee, WH; Shen, KL; Yu, CP | 1 |
Graham, AK; Herrington, CS; McGee, JO | 1 |
2 other study(ies) available for digoxigenin and Carcinoma in Situ
Article | Year |
---|---|
The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling.
Topics: Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cell Division; Cell Survival; Deoxyuracil Nucleotides; Digoxigenin; DNA Fragmentation; DNA Nucleotidylexotransferase; DNA, Neoplasm; Female; Genes, bcl-2; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Neoplasm Invasiveness; Receptors, Estrogen; Receptors, Progesterone; Tumor Suppressor Protein p53 | 1998 |
Interphase cytogenetics using biotin and digoxigenin labelled probes: III. Increased sensitivity and flexibility for detecting HPV in cervical biopsy specimens and cell lines.
Topics: Alkaline Phosphatase; Antibodies, Monoclonal; Biotin; Carcinoma in Situ; Cervix Uteri; Condylomata Acuminata; Digoxigenin; Digoxin; DNA Probes, HPV; Female; Fluorescent Antibody Technique; HeLa Cells; Humans; Interphase; Papillomaviridae; Uterine Cervical Neoplasms | 1991 |